PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jcinvestThe Journal of Clinical InvestigationCurrent IssueArchiveSubscriptionAbout the Journal
 
J Clin Invest. 1991 November; 88(5): 1596–1604.
PMCID: PMC295680

Cytogenetic and molecular genetic studies of follicular and papillary thyroid cancers.

Abstract

Cytogenetic studies have shown frequent clonal abnormalities in papillary carcinoma (PTC) and follicular carcinoma (FTC). Loss of heterozygosity (LOH) may suggest the presence of tumor suppressor genes and has not been reported in these neoplasms. These studies were undertaken to determine if consistent chromosomal abnormalities are associated with thyroid cancer, to determine likely regions for molecular genetic investigations, and to determine if there is allelic loss in thyroid tumors. Cytogenetic analysis of 26 PTC and 5 FTC showed clonal abnormalities in 9 and included -Y, +5, or inv(10)(q11.2q21.2) in PTC, and -Y or near haploidy in FTC. Using DNA probes specific for chromosomes 1, 3, 10, 16, and 17, we carried out restriction fragment length polymorphism analysis on 6 FTC, 3 follicular adenomas (FA), and 12 PTC. LOH of all informative loci on chromosome 3p was observed in all 6 FTC, but not in FA or PTC. No LOH was observed for loci mapped to chromosome 10 in PTC. Our results suggest: cytogenetic abnormalities of chromosome 10q are associated with PTC; cytogenetic and molecular abnormalities of chromosome 3 are associated with FTC; and a tumor suppressor gene may be present on the short arm of chromosome 3 important for the development or progression of FTC.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (2.6M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Hedinger C, Williams ED, Sobin LH. The WHO histological classification of thyroid tumors: a commentary on the second edition. Cancer. 1989 Mar 1;63(5):908–911. [PubMed]
  • Teyssier JR, Liautaud-Roger F, Ferre D, Patey M, Dufer J. Chromosomal changes in thyroid tumors. Relation with DNA content, karyotypic features, and clinical data. Cancer Genet Cytogenet. 1990 Dec;50(2):249–263. [PubMed]
  • Jenkins RB, Hay ID, Herath JF, Schultz CG, Spurbeck JL, Grant CS, Goellner JR, Dewald GW. Frequent occurrence of cytogenetic abnormalities in sporadic nonmedullary thyroid carcinoma. Cancer. 1990 Sep 15;66(6):1213–1220. [PubMed]
  • Olah E, Balogh E, Bojan F, Juhasz F, Stenszky V, Farid NR. Cytogenetic analyses of three papillary carcinomas and a follicular adenoma of the thyroid. Cancer Genet Cytogenet. 1990 Jan;44(1):119–129. [PubMed]
  • van den Berg E, Oosterhuis JW, de Jong B, Buist J, Vos A, Dam A, Vermeij B. Cytogenetics of thyroid follicular adenomas. Cancer Genet Cytogenet. 1990 Feb;44(2):217–222. [PubMed]
  • Antonini P, Venuat AM, Linares G, Caillou B, Berger R, Parmentier C. A translocation (7;10)(q35;q21) in a differentiated papillary carcinoma of the thyroid. Cancer Genet Cytogenet. 1989 Aug;41(1):139–144. [PubMed]
  • Bondeson L, Bengtsson A, Bondeson AG, Dahlenfors R, Grimelius L, Wedell B, Mark J. Chromosome studies in thyroid neoplasia. Cancer. 1989 Aug 1;64(3):680–685. [PubMed]
  • Bartnitzke S, Herrmann ME, Lobeck H, Zuschneid W, Neuhaus P, Bullerdiek J. Cytogenetic findings on eight follicular thyroid adenomas including one with a t(10;19). Cancer Genet Cytogenet. 1989 May;39(1):65–68. [PubMed]
  • Mark J, Ekedahl C, Dahlenfors R, Westermark B. Cytogenetical observations in five human anaplastic thyroid carcinomas. Hereditas. 1987;107(2):163–174. [PubMed]
  • Teyssier JR. Nonrandom chromosomal changes in human solid tumors: application of an improved culture method. J Natl Cancer Inst. 1987 Dec;79(6):1189–1198. [PubMed]
  • Fusco A, Grieco M, Santoro M, Berlingieri MT, Pilotti S, Pierotti MA, Della Porta G, Vecchio G. A new oncogene in human thyroid papillary carcinomas and their lymph-nodal metastases. Nature. 1987 Jul 9;328(6126):170–172. [PubMed]
  • Donghi R, Sozzi G, Pierotti MA, Biunno I, Miozzo M, Fusco A, Grieco M, Santoro M, Vecchio G, Spurr NK, et al. The oncogene associated with human papillary thyroid carcinoma (PTC) is assigned to chromosome 10 q11-q12 in the same region as multiple endocrine neoplasia type 2A (MEN2A). Oncogene. 1989 Apr;4(4):521–523. [PubMed]
  • Grieco M, Santoro M, Berlingieri MT, Melillo RM, Donghi R, Bongarzone I, Pierotti MA, Della Porta G, Fusco A, Vecchio G. PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas. Cell. 1990 Feb 23;60(4):557–563. [PubMed]
  • Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 1990 Jun 1;61(5):759–767. [PubMed]
  • Spurbeck JL, Carlson RO, Allen JE, Dewald GW. Culturing and robotic harvesting of bone marrow, lymph nodes, peripheral blood, fibroblasts, and solid tumors with in situ techniques. Cancer Genet Cytogenet. 1988 May;32(1):59–66. [PubMed]
  • Müllenbach R, Lagoda PJ, Welter C. An efficient salt-chloroform extraction of DNA from blood and tissues. Trends Genet. 1989 Dec;5(12):391–391. [PubMed]
  • Southern EM. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol. 1975 Nov 5;98(3):503–517. [PubMed]
  • Seizinger BR, Rouleau GA, Ozelius LJ, Lane AH, Farmer GE, Lamiell JM, Haines J, Yuen JW, Collins D, Majoor-Krakauer D, et al. Von Hippel-Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma. Nature. 1988 Mar 17;332(6161):268–269. [PubMed]
  • Weinberger C, Thompson CC, Ong ES, Lebo R, Gruol DJ, Evans RM. The c-erb-A gene encodes a thyroid hormone receptor. Nature. 1986 Dec 18;324(6098):641–646. [PubMed]
  • Kok K, Osinga J, Carritt B, Davis MB, van der Hout AH, van der Veen AY, Landsvater RM, de Leij LF, Berendsen HH, Postmus PE, et al. Deletion of a DNA sequence at the chromosomal region 3p21 in all major types of lung cancer. Nature. 1987 Dec 10;330(6148):578–581. [PubMed]
  • Nakamura Y, Culver M, Gillilan S, O'Connell P, Leppert M, Lathrop GM, Lalouel JM, White R. Isolation and mapping of a polymorphic DNA sequence pYNZ86.1 on chromosome 3 (D3S30). Nucleic Acids Res. 1987 Dec 10;15(23):10079–10079. [PMC free article] [PubMed]
  • Litt M, Litt R, Ballard L, Leppert M. An anonymous single-copy clone, p30-1-60, identifies a frequent RFLP on chromosome 3p [HGM9 no. D3S86]. Nucleic Acids Res. 1989 Apr 11;17(7):2883–2883. [PMC free article] [PubMed]
  • Naylor SL, Sakaguchi AY, Barker D, White R, Shows TB. DNA polymorphic loci mapped to human chromosomes 3, 5, 9, 11, 17, 18, and 22. Proc Natl Acad Sci U S A. 1984 Apr;81(8):2447–2451. [PubMed]
  • Bragg T, Nakamura Y, Jones C, White R. Isolation and mapping of a polymorphic DNA sequence (cTBQ7) on chromosome 10 [D10S28]. Nucleic Acids Res. 1988 Dec 9;16(23):11395–11395. [PMC free article] [PubMed]
  • Holm T, Nakamura Y, Ballard L, O'Connell P, Leppert M, Lathrop GM, Lalouel JM, White R. Isolation and mapping of a polymorphic DNA sequence pTHH54 on chromosome 10 [D10S13]. Nucleic Acids Res. 1988 Jan 11;16(1):372–372. [PMC free article] [PubMed]
  • Liou GI, Li Y, Wang C, Fong SL, Bhattacharya S, Bridges CD. Bgl II RFLP recognized by a human IRBP cDNA localized to chromosome 10. Nucleic Acids Res. 1987 Apr 10;15(7):3196–3196. [PMC free article] [PubMed]
  • Bragg T, Nakamura Y, Fujimoto E, O'Connell P, Leppert M, Lathrop GM, Lalouel JM, White R. Isolation and mapping of a polymorphic DNA sequence (pTB10.163) on chromosome 10 [D10S22]. Nucleic Acids Res. 1988 May 11;16(9):4185–4185. [PMC free article] [PubMed]
  • McDermid HE, Goodfellow PJ, Duncan AM, Brasch KR, Simpson NE, Souza CD, Holden JJ, White BN. A polymorphic locus, D10S5, at 10q21.1. Nucleic Acids Res. 1987 Jul 10;15(13):5498–5498. [PMC free article] [PubMed]
  • Nakamura Y, Bragg T, Myers R, O'Connell P, Leppert M, Lathrop GM, Lalouel JM, White R. Isolation and mapping of a polymorphic DNA sequence (pTB10.171) on chromosome 10 [D10S19]. Nucleic Acids Res. 1988 May 11;16(9):4187–4187. [PMC free article] [PubMed]
  • Litt M, Mueller OT, Shows TB, Litt R. A single copy subclone, p1-101, from cosmid 3-3B, defines three RFLPs on 10pter-q23 [HGM9 no. D10S4]. Nucleic Acids Res. 1987 Mar 25;15(6):2783–2783. [PMC free article] [PubMed]
  • Farrer LA, Castiglione CM, Kidd JR, Myers S, Carson N, Simpson NE, Kidd KK. A linkage group of five DNA markers on human chromosome 10. Genomics. 1988 Jul;3(1):72–77. [PubMed]
  • Reeders ST, Breuning MH, Davies KE, Nicholls RD, Jarman AP, Higgs DR, Pearson PL, Weatherall DJ. A highly polymorphic DNA marker linked to adult polycystic kidney disease on chromosome 16. Nature. 1985 Oct 10;317(6037):542–544. [PubMed]
  • Nakamura Y, Ballard L, Leppert M, O'Connell P, Lathrop GM, Lalouel JM, White R. Isolation and mapping of a polymorphic DNA sequence (pYNZ22) on chromosome 17p [D17S30]. Nucleic Acids Res. 1988 Jun 24;16(12):5707–5707. [PMC free article] [PubMed]
  • Feinberg AP, Vogelstein B. "A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity". Addendum. Anal Biochem. 1984 Feb;137(1):266–267. [PubMed]
  • Boring CC, Squires TS, Tong T. Cancer statistics, 1991. CA Cancer J Clin. 1991 Jan-Feb;41(1):19–36. [PubMed]
  • Williams ED. The aetiology of thyroid tumours. Clin Endocrinol Metab. 1979 Mar;8(1):193–207. [PubMed]
  • Lemoine NR, Mayall ES, Wyllie FS, Farr CJ, Hughes D, Padua RA, Thurston V, Williams ED, Wynford-Thomas D. Activated ras oncogenes in human thyroid cancers. Cancer Res. 1988 Aug 15;48(16):4459–4463. [PubMed]
  • Lemoine NR, Mayall ES, Wyllie FS, Williams ED, Goyns M, Stringer B, Wynford-Thomas D. High frequency of ras oncogene activation in all stages of human thyroid tumorigenesis. Oncogene. 1989 Feb;4(2):159–164. [PubMed]
  • Wyllie FS, Lemoine NR, Williams ED, Wynford-Thomas D. Structure and expression of nuclear oncogenes in multi-stage thyroid tumorigenesis. Br J Cancer. 1989 Oct;60(4):561–565. [PubMed]
  • Wright PA, Lemoine NR, Mayall ES, Wyllie FS, Hughes D, Williams ED, Wynford-Thomas D. Papillary and follicular thyroid carcinomas show a different pattern of ras oncogene mutation. Br J Cancer. 1989 Oct;60(4):576–577. [PubMed]
  • Brennan MD, Bergstralh EJ, van Heerden JA, McConahey WM. Follicular thyroid cancer treated at the Mayo Clinic, 1946 through 1970: initial manifestations, pathologic findings, therapy, and outcome. Mayo Clin Proc. 1991 Jan;66(1):11–22. [PubMed]
  • Teyssier JR. The chromosomal analysis of human solid tumors. A triple challenge. Cancer Genet Cytogenet. 1989 Jan;37(1):103–125. [PubMed]
  • Khosla S, Patel VM, Hay ID, Schaid DJ, Grant CS, van Heerden JA, Thibodeau SN. Loss of heterozygosity suggests multiple genetic alterations in pheochromocytomas and medullary thyroid carcinomas. J Clin Invest. 1991 May;87(5):1691–1699. [PMC free article] [PubMed]
  • Kovacs G, Erlandsson R, Boldog F, Ingvarsson S, Müller-Brechlin R, Klein G, Sümegi J. Consistent chromosome 3p deletion and loss of heterozygosity in renal cell carcinoma. Proc Natl Acad Sci U S A. 1988 Mar;85(5):1571–1575. [PubMed]
  • Mooibroek H, Osinga J, Postmus PE, Carritt B, Buys CH. Loss of heterozygosity for a chromosome 3 sequence presumably at 3p21 in small cell lung cancer. Cancer Genet Cytogenet. 1987 Aug;27(2):361–365. [PubMed]
  • Naylor SL, Carritt B. Report of the committee on the genetic constitution of chromosome 3. Cytogenet Cell Genet. 1990;55(1-4):92–96. [PubMed]
  • Mitelman F, Kaneko Y, Trent JM. Report of the committee on chromosome changes in neoplasia. Cytogenet Cell Genet. 1990;55(1-4):358–386. [PubMed]
  • Pierre RV, Hoagland HC. 45,X cell lines in adult men: loss of Y chromosome, a normal aging phenomenon? Mayo Clin Proc. 1971 Jan;46(1):52–55. [PubMed]
  • Heim S, Mandahl N, Jin Y, Strömblad S, Lindström E, Salford LG, Mitelman F. Trisomy 7 and sex chromosome loss in human brain tissue. Cytogenet Cell Genet. 1989;52(3-4):136–138. [PubMed]
  • Becher R, Gibas Z, Karakousis C, Sandberg AA. Nonrandom chromosome changes in malignant melanoma. Cancer Res. 1983 Oct;43(10):5010–5016. [PubMed]
  • Pedersen MI, Bennett JW, Wang N. Nonrandom chromosome structural aberrations and oncogene loci in human malignant melanoma. Cancer Genet Cytogenet. 1986 Feb 1;20(1-2):11–27. [PubMed]
  • Smeets W, Pauwels R, Laarakkers L, Debruyne F, Geraedts J. Chromosomal analysis of bladder cancer. III. Nonrandom alterations. Cancer Genet Cytogenet. 1987 Nov;29(1):29–41. [PubMed]
  • Vanni R, Scarpa RM, Nieddu M, Usai E. Cytogenetic investigation on 30 bladder carcinomas. Cancer Genet Cytogenet. 1988 Jan;30(1):35–42. [PubMed]
  • Popescu NC, Chahinian AP, DiPaolo JA. Nonrandom chromosome alterations in human malignant mesothelioma. Cancer Res. 1988 Jan 1;48(1):142–147. [PubMed]

Articles from The Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation